{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T09:56:09Z","timestamp":1790589369111,"version":"4.1.0"},"reference-count":124,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Tertiary lymphoid structures (TLSs) are associated with antitumor immunity and have prompted efforts to induce lymphoid organization within tumors. The central interpretive problem is whether the resulting tissue changes contribute to treatment benefit or accompany effects mediated by other cells. Building on established TLS biology, this Review compares the cellular targets, functional measurements, and antitumor outcomes of stromal, endothelial, and antigen-presenting-cell interventions, with particular attention to cancer-associated fibroblasts (CAFs). Across experimental systems, defined CAF states support chemokine production and lymphocyte recruitment, whereas vascular entry and antigen-dependent T-cell responses are demonstrated through distinct interventions. The synthesis distinguishes a stromal contribution to immune organization from evidence that this contribution is required for tumor control, preserving the model and anatomical setting in which each relationship was tested. Mechanistic support comes mainly from murine and engineered systems, while human studies chiefly establish spatial relationships and clinical associations. For therapies that remodel TLS-associated niches, this comparison identifies the induced functions whose contribution to treatment benefit needs to be tested before tissue changes are used to guide clinical treatment.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1958533","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T09:10:14Z","timestamp":1790586614000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["From TLS architecture to functional immune niches: division of labor among CAFs, HEVs, and antigen-presenting cells in cancer immunotherapy"],"prefix":"10.3389","volume":"17","author":[{"given":"Li","family":"Xiao","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Zigong First People\u2019s Hospital","place":["Zigong, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Zigong First People\u2019s Hospital","place":["Zigong, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Zigong First People\u2019s Hospital","place":["Zigong, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-024-00728-0","article-title":"Tertiary lymphoid structures in anticancer immunity","volume":"24","author":"Teillaud","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-23-2716","article-title":"LT\u03b2R agonism promotes antitumor immune responses via modulation of the tumor microenvironment","volume":"84","author":"An","year":"2024","journal-title":"Cancer Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01609","article-title":"Induction of tertiary lymphoid structures with antitumor function by a lymph node-derived stromal cell line","volume":"9","author":"Zhu","year":"2018","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02191-9","article-title":"Single cell and spatial analysis of immune-hot and immune-cold tumours identifies fibroblast subtypes associated with distinct immunological niches and positive immunotherapy response","volume":"24","author":"Jenkins","year":"2025","journal-title":"Mol Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2025.03.004","article-title":"Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics","volume":"43","author":"Liu","year":"2025","journal-title":"Cancer Cell"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/s41467-025-57465-7","article-title":"Antigen-presenting cancer associated fibroblasts enhance antitumor immunity and predict immunotherapy response","volume":"16","author":"Song","year":"2025","journal-title":"Nat Commun"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2026.03.004","article-title":"Myofibroblast programming blocks differentiation of TLS-organizing fibroblastic reticular cells in pancreatic cancer","volume":"44","author":"Kirschstein","year":"2026","journal-title":"Cancer Cell"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102200","article-title":"Interferon-responsive HEVs drive tumor tertiary lymphoid structure formation and predict immunotherapy response in nasopharyngeal carcinoma","volume":"6","author":"Liu","year":"2025","journal-title":"Cell Rep Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202308760","article-title":"Rapid generation of hPSC-derived high endothelial venule organoids with in vivo ectopic lymphoid tissue capabilities","volume":"36","author":"Wang","year":"2024","journal-title":"Adv Mater (Deerfield Beach Fla)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2026-014914","article-title":"FLT3L-secreting cDC1 in situ vaccination enhances antitumor immunity and synergizes with PD-1 blockade in murine non-small cell lung cancer","volume":"14","author":"Abascal","year":"2026","journal-title":"J Immunother Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.04.010","article-title":"Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma","volume":"41","author":"Ramachandran","year":"2023","journal-title":"Cancer Cell"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1369626","article-title":"Tertiary lymphoid structures in cancer: maturation and induction","volume":"15","author":"Chen","year":"2024","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12943-024-01980-6","article-title":"Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-23-3325","article-title":"Exploiting tertiary lymphoid structures to stimulate antitumor immunity and improve immunotherapy efficacy","volume":"84","author":"Petroni","year":"2024","journal-title":"Cancer Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s40164-025-00695-8","article-title":"In-depth insight into tumor-infiltrating stromal cells linked to tertiary lymphoid structures and their prospective function in cancer immunotherapy","volume":"14","author":"Radandish","year":"2025","journal-title":"Exp Hematol Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13045-026-01814-6","article-title":"Cancer-associated fibroblasts and tertiary lymphoid structure orchestrate the spatial architecture of tumor immunity","volume":"19","author":"Tang","year":"2026","journal-title":"J Hematol Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.117574","article-title":"Tumor vasculature-mediated formation of tertiary lymphoid structures: unraveling spatiotemporal coupling to optimize vasculo-immunotherapy","volume":"244","author":"Lei","year":"2025","journal-title":"Biochem Pharmacol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1693507","article-title":"Pleiotropic and multicellular roles of lymphotoxin beta receptor in solid tumor immunity and therapeutic targeting","volume":"17","author":"Anshu","year":"2026","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.07.006","article-title":"CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis","volume":"42","author":"Zhang","year":"2024","journal-title":"Cancer Cell"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.12.028","article-title":"Multiplexed 3D atlas of state transitions and immune interaction in colorectal cancer","volume":"186","author":"Lin","year":"2023","journal-title":"Cell"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2022.119399","article-title":"Murine neonatal dermal fibroblast acquires a lymphoid tissue organizer cell-like activity upon synergistic activation of TNF-\u03b1 receptor and LT\u03b2 receptor","volume":"1870","author":"Jin","year":"2022","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109422","article-title":"Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts","volume":"36","author":"Rodriguez","year":"2021","journal-title":"Cell Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"7114","DOI":"10.1038\/ncomms8114","article-title":"Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity","volume":"6","author":"Peske","year":"2015","journal-title":"Nat Commun"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.157215","article-title":"CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer","volume":"7","author":"Ukita","year":"2022","journal-title":"JCI Insight"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/cas.70105","article-title":"CXCL13 and CCL21 induce tertiary lymphoid structures and enhance the efficacy of immunotherapy for melanoma","volume":"116","author":"Yoshimitsu","year":"2025","journal-title":"Cancer Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2019.02.003","article-title":"Collagen fiber structure guides 3D motility of cytotoxic T lymphocytes","author":"Pruitt","year":"2019","journal-title":"Matrix Biol J Int Soc For Matrix Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-25-4402","article-title":"FAP-targeted LT\u03b2R agonist drives HEV differentiation and immune niche formation for improved immunotherapy response in solid tumors","volume":"32","author":"Bianchi","year":"2026","journal-title":"Clin Cancer Res Off J Am Assoc For Cancer Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-71161-0","article-title":"The CD4+ T cell population partners with Tpex CD8+ T cells to mediate antitumor immunity in the tumor microenvironment","volume":"17","author":"Takei","year":"2026","journal-title":"Nat Commun"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.09.007","article-title":"The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions","volume":"42","author":"MacFawn","year":"2024","journal-title":"Cancer Cell"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1905301116","article-title":"Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology","volume":"116","author":"Nayar","year":"2019","journal-title":"PNAS"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk8805","article-title":"Spatiotemporal architecture of immune cells and cancer-associated fibroblasts in high-grade serous ovarian carcinoma","volume":"10","author":"Xu","year":"2024","journal-title":"Sci Adv"},{"key":"B32","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/s12967-025-06358-w","article-title":"Spatial relationships and interactions of immune cell niches are linked to the pathologic response of muscle-invasive bladder cancer to neoadjuvant therapy","volume":"23","author":"Wahafu","year":"2025","journal-title":"J Transl Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.70260","article-title":"Single-cell and spatial analysis reveal the differences between left-sided and right-sided colorectal cancer","author":"Zhang","year":"2026","journal-title":"Cell Proliferation"},{"key":"B34","doi-asserted-by":"publisher","first-page":"11231","DOI":"10.1038\/s41598-019-47755-8","article-title":"NOVA1 induction by inflammation and NOVA1 suppression by epigenetic regulation in head and neck squamous cell carcinoma","volume":"9","author":"Kim","year":"2019","journal-title":"Sci Rep"},{"key":"B35","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00262-026-04348-5","article-title":"Association of CCL21+ CAFs with B-cell recruitment and TLS maturation in penile squamous cell carcinoma","volume":"75","author":"Li","year":"2026","journal-title":"Cancer Immunol Immunother CII"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/cas.70320","article-title":"Neoadjuvant therapy-induced remodeling in pancreatic ductal adenocarcinoma: multimodal spatial analysis and prognosis","volume":"117","author":"Zhang","year":"2026","journal-title":"Cancer Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10030490","article-title":"Nerve fibers in the tumor microenvironment are co-localized with lymphoid aggregates in pancreatic cancer","volume":"10","author":"Heij","year":"2021","journal-title":"J Clin Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202416526","article-title":"Loss of fibronectin fiber tension in glioblastoma is associated with microvascular proliferations and immune cell infiltration","volume":"12","author":"Crestani","year":"2025","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17203351","article-title":"Tertiary lymphoid structures are associated with favorable clinical outcomes and negatively correlated with cancer-associated fibroblasts in esophageal cancer","volume":"17","author":"Kunitomo","year":"2025","journal-title":"Cancers"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goad034","article-title":"Dynamic heterogeneity of colorectal cancer during progression revealed clinical risk-associated cell types and regulations in single-cell resolution and spatial context","volume":"11","author":"Ke","year":"2023","journal-title":"Gastroenterol Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-018-2336-y","article-title":"Immune cell expression of TGF\u03b21 in cancer with lymphoid stroma: dendritic cell and regulatory T cell contact","volume":"472","author":"Ohtani","year":"2018","journal-title":"Virchows Archiv Int J Pathol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3416","article-title":"The immunosuppressive niche of soft-tissue sarcomas is sustained by tumor-associated macrophages and characterized by intratumoral tertiary lymphoid structures","volume":"26","author":"Chen","year":"2020","journal-title":"Clin Cancer Res Off J Am Assoc For Cancer Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2117065119","article-title":"Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155\/TIGIT axis","volume":"119","author":"Ozmadenci","year":"2022","journal-title":"PNAS"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-22-0110","article-title":"Sensory nerves impede the formation of tertiary lymphoid structures and development of protective antimelanoma immune responses","volume":"10","author":"Vats","year":"2022","journal-title":"Cancer Immunol Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-006939","article-title":"Tobacco exposure primes the secretion of CCL21 positively associated with tertiary lymphoid structure and response to immunotherapy","volume":"11","author":"Yin","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-08426-5","article-title":"IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer","volume":"638","author":"Amisaki","year":"2025","journal-title":"Nature"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2026.117009","article-title":"FAK inhibition in ovarian cancer releases omega-3 fatty acids to program CXCL13-producing anti-tumor resident peritoneal macrophages","volume":"45","author":"Chen","year":"2026","journal-title":"Cell Rep"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-026-15647-6","article-title":"Spatial atlas of gastric cancer reveals macrophage-driven stromal activation via ICAM1+ smooth muscle cells","volume":"26","author":"Cheng","year":"2026","journal-title":"BMC Cancer"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adr1299","article-title":"Intratumoral antigen-presenting cell activation by a nanovesicle for the concurrent tertiary lymphoid structure de novo neogenesis","volume":"11","author":"Cheng","year":"2025","journal-title":"Sci Adv"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-025-02552-x","article-title":"A bioactive soluble recombinant mouse LIGHT promotes effective tumor immune cell infiltration delaying tumor growth","volume":"103","author":"Del Rio","year":"2025","journal-title":"J Mol Med (Berlin Germany)"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11071238","article-title":"Loss of lymphotoxin alpha-expressing memory B cells correlates with metastasis of human primary melanoma","volume":"11","author":"Werner","year":"2021","journal-title":"Diagn (Basel Switzerland)"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/cas.16371","article-title":"CXCL9 and CXCL13 shape endometrial cancer immune-activated microenvironment via tertiary lymphoid structure formation","volume":"116","author":"Nagase","year":"2025","journal-title":"Cancer Sci"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00563","article-title":"A unique cellular and molecular microenvironment is present in tertiary lymphoid organs of patients with spontaneous prostate cancer regression","volume":"8","author":"Garc\u00eda-Hern\u00e1ndez","year":"2017","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1322238","article-title":"Tbet and IL-36\u03b3 cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment","volume":"6","author":"Weinstein","year":"2017","journal-title":"Oncoimmunology"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-018-2259-0","article-title":"Association of IL-36\u03b3 with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer","volume":"68","author":"Weinstein","year":"2018","journal-title":"Cancer Immunol Immunother CII"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2024.2406576","article-title":"Immune priming and induction of tertiary lymphoid structures in a cord-blood humanized mouse model of gastrointestinal stromal tumor","volume":"13","author":"He","year":"2024","journal-title":"Oncoimmunology"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1343839","article-title":"4-nitroquinoline 1-oxide-induced oral epithelial lesions exhibit time- and stage-dependent changes in the tumor immune microenvironment","volume":"14","author":"Sell\u00e6g","year":"2024","journal-title":"Front Oncol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-21-0369","article-title":"Molecular signature of tumor-associated high endothelial venules that can predict breast cancer survival","volume":"10","author":"Sawada","year":"2022","journal-title":"Cancer Immunol Res"},{"key":"B59","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12935-025-04161-7","article-title":"Single-cell spatial analysis identifies ID1-high endothelial cells in tertiary lymphoid structures as predictors of durable response to immunotherapy in non-small cell lung cancer","volume":"26","author":"Matsumoto","year":"2026","journal-title":"Cancer Cell Int"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1302761","article-title":"Immune checkpoint ligands expressed on mature high endothelial venules predict poor prognosis of NSCLC: have a relationship with CD8+ T lymphocytes infiltration","volume":"15","author":"Luo","year":"2024","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13513","article-title":"High endothelial venule is a prognostic immune-related biomarker in patients with resected intrahepatic cholangiocarcinoma","volume":"56","author":"Zhou","year":"2023","journal-title":"Cell Proliferation"},{"key":"B62","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s00262-025-04265-z","article-title":"Tumor-associated high endothelial venules are associated with enhanced lymphocyte infiltration and favorable prognosis in resected hepatocellular carcinoma","volume":"75","author":"Aoyama","year":"2025","journal-title":"Cancer Immunol Immunother CII"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3390\/cells12081176","article-title":"Tertiary lymphoid structures (TLSs) and stromal blood vessels have significant and heterogeneous impact on recurrence, lymphovascular and perineural invasion amongst breast cancer molecular subtypes","volume":"12","author":"Barb","year":"2023","journal-title":"Cells"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2025.12.011","article-title":"B cells disrupt tertiary lymphoid structure formation and suppress anti-tumor immunity","volume":"44","author":"Chen","year":"2026","journal-title":"Cancer Cell"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.cophys.2023.100705","article-title":"Regulation, maintenance, and remodeling of high endothelial venules in homeostasis, inflammation, and cancer","volume":"36","author":"Ruddle","year":"2023","journal-title":"Curr Opin Physiol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"174","DOI":"10.21037\/tlcr-2026-1-0050","article-title":"The impact of local tumor immune responses on prognosis in resected lung adenocarcinoma","volume":"15","author":"Ichiki","year":"2026","journal-title":"Trans Lung Cancer Res"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.312","article-title":"A pilot study of camrelizumab with docetaxel and cisplatin for the first line treatment in recurrent\/metastatic oral squamous cell carcinoma","volume":"4","author":"Ju","year":"2023","journal-title":"MedComm"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-024-00896-w","article-title":"Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma","volume":"6","author":"Jammihal","year":"2025","journal-title":"Nat Cancer"},{"key":"B69","doi-asserted-by":"publisher","first-page":"6688","DOI":"10.1038\/s41467-025-61691-4","article-title":"Constitutive inflammation and epithelial-mesenchymal transition dictate sensitivity to nivolumab in CONFIRM: a placebo-controlled, randomised phase III trial","volume":"16","author":"Fennell","year":"2025","journal-title":"Nat Commun"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2025.09.4169","article-title":"Nivolumab in metastatic clear-cell renal cell carcinoma: an integrative biomarker analysis from the NIVOREN GETUG-AFU 26 phase 2 study","author":"Flippot","year":"2025","journal-title":"Eur Urol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-026-02445-2","article-title":"Chemokine-defined macrophage niches establish spatial organization of tumor immunity","volume":"27","author":"Ghosh","year":"2026","journal-title":"Nat Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2026.106280","article-title":"TCF1+CD4+ T cells and microglia co-orchestrate tertiary lymphoid structures to enhance prognosis and immunotherapy in non-small cell lung cancer with brain metastases","volume":"127","author":"Yu","year":"2026","journal-title":"EBioMedicine"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001136","article-title":"CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer","volume":"9","author":"Yang","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-012224","article-title":"Tertiary lymphoid structures in Merkel cell carcinoma facilitate na\u00efve and central memory T-cell infiltration linked to immunotherapy response","volume":"13","author":"Srinivas","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.13403","article-title":"Tertiary lymphoid structures in head and neck squamous cell carcinoma improve prognosis by recruiting CD8+ T cells","volume":"17","author":"Wang","year":"2023","journal-title":"Mol Oncol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"26255","DOI":"10.1038\/s41598-024-76044-2","article-title":"Revealing molecular mechanisms of early-onset tongue cancer by spatial transcriptomics","volume":"14","author":"Patysheva","year":"2024","journal-title":"Sci Rep"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001823","article-title":"Intratumoral CXCL13+CD8+T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma","volume":"9","author":"Dai","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001188","article-title":"Infiltrating pattern and prognostic value of tertiary lymphoid structures in resected non-functional pancreatic neuroendocrine tumors","volume":"8","author":"Zhang","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2022.08.005","article-title":"Tumor-infiltrating lymphocytes (TIL), tertiary lymphoid structures (TLS), and expression of PD-1, TIM-3, LAG-3 on TIL in invasive and in situ ductal breast carcinomas and their relationship with prognostic factors","volume":"22","author":"Acar","year":"2022","journal-title":"Clin Breast Cancer"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-022-06787-x","article-title":"Integrative prognostic analysis of tumor-infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapy","volume":"197","author":"Yazaki","year":"2022","journal-title":"Breast Cancer Res Treat"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3390\/cancers18010129","article-title":"Prognostic value of lymphoid infiltration and aggregation in cervical cancer","volume":"18","author":"Gorecki","year":"2025","journal-title":"Cancers"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2023.06.015","article-title":"LIGHT\/TNFSF14 promotes CAR-T cell trafficking and cytotoxicity through reversing immunosuppressive tumor microenvironment","volume":"31","author":"Zhang","year":"2023","journal-title":"Mol Ther J Am Soc Gene Ther"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102510","article-title":"Potentiating immunotherapy in \"immune-cold\" solid tumors through orchestrating T cell immunity via tumor-specific genetic engineering","volume":"6","author":"He","year":"2025","journal-title":"Cell Rep Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001906","article-title":"STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment","volume":"9","author":"Chelvanambi","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2022.2093054","article-title":"Oncolytic adenovirus promotes vascular normalization and nonclassical tertiary lymphoid structure formation through STING-mediated DC activation","volume":"11","author":"He","year":"2022","journal-title":"Oncoimmunology"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2409560122","article-title":"Chemokine\/cytokine-releasing biomaterials induce in situ tertiary lymphoid-like structures and enhance antitumor immunity","volume":"122","author":"Falahat","year":"2025","journal-title":"PNAS"},{"key":"B87","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12951-025-03301-5","article-title":"Radiotherapy-derived engineered stem cell exosomes improve anti-glioma immunotherapy by promoting the formation of tertiary lymphoid structure and improve the release of type I interferon","volume":"23","author":"Li","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2024.05.009","article-title":"CCL9\/CCR1 axis-driven chemotactic nanovesicles for attenuating metastasis of SMAD4-deficient colorectal cancer by trapping TGF-\u03b2","volume":"14","author":"Niu","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202507159","article-title":"Tailoring vascular-immune homeostasis via manganese-DNA complex-armed immunogenic extracellular vesicles for pancreatic cancer immunotherapy","volume":"13","author":"Jiang","year":"2025","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202203842","article-title":"Inducing ectopic T cell clusters using stromal vascular fraction spheroid-based immunotherapy to enhance anti-tumor immunity","volume":"9","author":"Lee","year":"2022","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ado8395","article-title":"Synthetic biology-driven induction of mature TLS formation enhances antitumor immunity in colorectal cancer","volume":"17","author":"Mi","year":"2025","journal-title":"Sci Transl Med"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2205378119","article-title":"Aging-associated and CD4 T-cell-dependent ectopic CXCL13 activation predisposes to anti-PD-1 therapy-induced adverse events","volume":"119","author":"Tsukamoto","year":"2022","journal-title":"PNAS"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-011648","article-title":"FMO2+ cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma","volume":"13","author":"Xu","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.675146","article-title":"A standardized analysis of tertiary lymphoid structures in human melanoma: disease progression- and tumor site-associated changes with germinal center alteration","volume":"12","author":"Werner","year":"2021","journal-title":"Front Immunol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1186\/s12967-023-04336-8","article-title":"Spatial heterogeneity of tumor microenvironment influences the prognosis of clear cell renal cell carcinoma","volume":"21","author":"Zhang","year":"2023","journal-title":"J Transl Med"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1328602","article-title":"Quantitative multiplex immunohistochemistry reveals inter-patient lymphovascular and immune heterogeneity in primary cutaneous melanoma","volume":"15","author":"Femel","year":"2024","journal-title":"Front Immunol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41698-024-00579-w","article-title":"Deep learning on tertiary lymphoid structures in hematoxylin-eosin predicts cancer prognosis and immunotherapy response","volume":"8","author":"Chen","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000001684","article-title":"Deciphering tertiary lymphoid structure heterogeneity reveals prognostic signature and therapeutic potentials for colorectal cancer: a multicenter retrospective cohort study","volume":"110","author":"Lei","year":"2024","journal-title":"Int J Surg (London England)"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.labinv.2025.104091","article-title":"Immune biomarkers on tissue microarray cores support the presence of adjacent tertiary lymphoid structures in soft tissue sarcoma","volume":"105","author":"Shenasa","year":"2025","journal-title":"Lab Invest A J Tech Methods Pathol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00262-025-04205-x","article-title":"Assessment of tertiary lymphoid structures via 18F-FDG PET\/CT scan in patients with pancreatic adenocarcinoma","volume":"74","author":"Yan","year":"2025","journal-title":"Cancer Immunol Immunother CII"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-025-00861-6","article-title":"Integrating single-nucleus barcoding with spatial transcriptomics via Stamp-seq to reveal immunotherapy response-enhancing functional modules in NSCLC","volume":"12","author":"Pan","year":"2026","journal-title":"Cell Discov"},{"key":"B102","doi-asserted-by":"publisher","first-page":"104","DOI":"10.21037\/tcr-2025-1717","article-title":"Multiomics study on the tertiary lymphatic structure signature of colon cancer","volume":"15","author":"Wang","year":"2026","journal-title":"Trans Cancer Res"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2025.2466308","article-title":"Spatial characterization of tertiary lymphoid structures as predictive biomarkers for immune checkpoint blockade in head and neck squamous cell carcinoma","volume":"14","author":"Ruiz-Torres","year":"2025","journal-title":"Oncoimmunology"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14023","article-title":"Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinoma","volume":"110","author":"Kuwabara","year":"2019","journal-title":"Cancer Sci"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-2495","article-title":"Modulation of the human pancreatic ductal adenocarcinoma immune microenvironment by stereotactic body radiotherapy","volume":"28","author":"Mills","year":"2021","journal-title":"Clin Cancer Res Off J Am Assoc For Cancer Res"},{"key":"B106","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41698-024-00533-w","article-title":"Tertiary lymphoid structures predict survival and response to neoadjuvant therapy in locally advanced rectal cancer","volume":"8","author":"Wang","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217178","article-title":"Survival benefit and spatial properties of tertiary lymphoid structures in esophageal squamous cell carcinoma with neoadjuvant therapies","volume":"601","author":"Huang","year":"2024","journal-title":"Cancer Lett"},{"key":"B108","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.1038\/s41467-025-59004-w","article-title":"Efficacy, safety and single-cell analysis of neoadjuvant immunochemotherapy in locally advanced oral squamous cell carcinoma: a phase II trial","volume":"16","author":"Xiang","year":"2025","journal-title":"Nat Commun"},{"key":"B109","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12885-025-15529-3","article-title":"High endothelial venules abundance in tertiary lymphoid structures: a prognostic biomarker in non-small cell lung cancer with neoadjuvant immunochemotherapy","volume":"26","author":"Zhang","year":"2026","journal-title":"BMC Cancer"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1177\/17588359261424663","article-title":"Stromal tumor-associated eosinophils predict therapeutic resistance and survival in locally advanced tongue squamous cell carcinoma after neoadjuvant therapy","volume":"18","author":"Huang","year":"2026","journal-title":"Ther Adv Med Oncol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1186\/s12967-026-07950-4","article-title":"Spatial distribution analysis of tertiary lymphoid structures in esophageal squamous cell carcinoma predicts patient survival and response to neoadjuvant chemo-immunotherapy","volume":"24","author":"Wang","year":"2026","journal-title":"J Transl Med"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71889","article-title":"Neoadjuvant immunochemotherapy increases the abundance of tertiary lymphoid structures and lymphocyte subpopulations is associated with prognosis of esophageal squamous cell carcinoma","volume":"15","author":"Li","year":"2026","journal-title":"Cancer Med"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.euros.2026.05.017","article-title":"Early efficacy and exploratory biomarker data of Bel-sar in patients with intermediate-risk and high-risk non-muscle-invasive bladder cancer","volume":"89","author":"Linehan","year":"2026","journal-title":"Eur Urol Open Sci"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-026-02746-w","article-title":"Neoadjuvant tislelizumab (anti-PD-1 antibody) plus chemotherapy in patients with advanced epithelial ovarian cancer: the exploratory NAIVE trial","volume":"11","author":"Zhang","year":"2026","journal-title":"Signal Transduction Targeted Ther"},{"key":"B115","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41392-025-02278-9","article-title":"Reshaping the tumor microenvironment of cold soft-tissue sarcomas with anti-angiogenics: a phase 2 trial of regorafenib combined with avelumab","volume":"10","author":"Toulmonde","year":"2025","journal-title":"Signal Transduction Targeted Ther"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13841","article-title":"Spatial tertiary lymphoid structures imply response to anti-PD-1 plus anlotinib in advanced non-small cell lung cancer","volume":"173","author":"Ma","year":"2024","journal-title":"Immunology"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2026.101020","article-title":"Immune-related pathological features and predictive score in intrahepatic cholangiocarcinoma treated with combined conversion immunotherapy","volume":"39","author":"Chen","year":"2026","journal-title":"Mod Pathol Off J United States Can Acad Pathol Inc"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0057-z","article-title":"A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade","volume":"24","author":"Thommen","year":"2018","journal-title":"Nat Med"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.101934","article-title":"Spatially resolved transcriptomics reveal the determinants of primary resistance to immunotherapy in NSCLC with mature tertiary lymphoid structures","volume":"6","author":"Peyraud","year":"2025","journal-title":"Cell Rep Med"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14615","article-title":"Metformin changes the immune microenvironment of colorectal cancer in patients with type 2 diabetes mellitus","volume":"111","author":"Saito","year":"2020","journal-title":"Cancer Sci"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1551259","article-title":"High expression of CXCL13 predicts a favorable response to immunotherapy by upregulating CXCR5+CD8+ T-cell infiltration in gastric cancer","volume":"16","author":"Xu","year":"2025","journal-title":"Front Immunol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-0479","article-title":"Spatial dynamics of T- and B-cell responses predicts clinical outcome of resectable and unresectable hepatocellular carcinoma","volume":"30","author":"Kurebayashi","year":"2024","journal-title":"Clin Cancer Res Off J Am Assoc For Cancer Res"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115554","article-title":"Quantitatively defined stromal B cell aggregates are associated with response to checkpoint inhibitors in unresectable melanoma","volume":"44","author":"Smithy","year":"2025","journal-title":"Cell Rep"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0029","article-title":"Distinct tertiary lymphoid structure associations and their prognostic relevance in HER2 positive and negative breast cancers","volume":"22","author":"Liu","year":"2017","journal-title":"Oncologist"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1958533\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T09:10:15Z","timestamp":1790586615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1958533\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":124,"alternative-id":["10.3389\/fimmu.2026.1958533"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1958533","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"article-number":"1958533"}}